#$%^&*AU2016204723A120160728.pdf#####H: RBR jIntenvoen RPo,,IlDCC RBRU 461720_Ldox-7/07/2006 ABSTRACT The invention concerns the use of a nicotinic acetylcholine receptor alpha 7 activators for the treatment, prevention or delay of progression of a Movement Disorder selected from 5 Dystonia., Dyskinesia, Chorea, Restless Legs Syndrome, Tics, Tremor, Myoclonus, Startle, Stiff Person Syndrome, Gait Disorder, Parkinson's Disease and Symptomatic Parkinsonism.WO 20121101060 PCTIEP20I 21650893 114 El v ~ unv Mt r LID j ci lii ii n m flrt li brA ~4 it 23-j 2O~ tr*N -I 7 1>；-i iLl >；1 _____ 90 N0 V Fig re I
